{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:24Z","timestamp":1792431444048,"version":"4.5.0"},"reference-count":147,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Antibiotics have always been considered as one of the most relevant discoveries of the twentieth century. Unfortunately, the dawn of the antibiotic era has sadly corresponded to the rise of the phenomenon of antimicrobial resistance (AMR), which is a natural process whereby microbes evolve in such a way to withstand the action of drugs. In this context, the identification of new potential antimicrobial targets and\/or the identification of new chemical entities as antimicrobial drugs are in great demand. To date, among the many possible approaches used to deal with antibiotic resistance is the use of antibiotic adjuvants that hit bacterial non-essential targets. In this review, the author focuses on the discovery of antibiotic adjuvants and on new tools to study and reduce the prevalence of resistant bacterial infections.<\/jats:p>","DOI":"10.3390\/ijms20235844","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T02:49:27Z","timestamp":1574390967000},"page":"5844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":240,"title":["Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-6966","authenticated-orcid":false,"given":"Giannamaria","family":"Annunziato","sequence":"first","affiliation":[{"name":"Probes for Targets Group (P4T group), Department of food and Drug, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","article-title":"A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1016\/j.bmcl.2014.06.053","article-title":"Confronting the challenges of discovery of novel antibacterial agents","volume":"24","author":"Singh","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.3390\/s111009450","article-title":"Biosensor Applications in the Field of Antibiotic Research\u2014A Review of Recent Developments","volume":"11","author":"Bendas","year":"2011","journal-title":"Sensors"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1465-0691.2004.1006.x","article-title":"Antibacterial drug discovery: Is it all downhill from here?","volume":"10","author":"Projan","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/cid\/ciu392","article-title":"The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett","volume":"59","author":"Spellberg","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"PMC-S14459","DOI":"10.4137\/PMC.S14459","article-title":"Antibiotics and Bacterial Resistance in the 21st Century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: A rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11648\/j.sjcm.20180702.11","article-title":"Current Review on Molecular and Phenotypic Mechanism of Bacterial Resistance to Antibiotic","volume":"7","author":"Admassie","year":"2018","journal-title":"Sci. J. Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular mechanisms that confer antibacterial drug resistance","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2017.08.027","article-title":"Antibiotic adjuvants\u2014A strategy to unlock bacterial resistance to antibiotics","volume":"27","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nrmicro2693","article-title":"Tackling antibiotic resistance","volume":"9","author":"Bush","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1473-3099(16)30386-3","article-title":"A global call from five countries to collaborate in antibiotic stewardship: United we succeed, divided we might fail","volume":"17","author":"Goff","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","first-page":"277","article-title":"The Antibiotic Resistance Crisis","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014The need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic Adjuvants: Rescuing Antibiotics from Resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: A new paradigm for antimicrobial therapy","volume":"3","author":"Clatworthy","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1021\/acs.chemrev.6b00676","article-title":"Chemical Strategies to Target Bacterial Virulence","volume":"117","author":"Garland","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00001432-199912000-00001","article-title":"Antibiotic efflux mechanisms","volume":"12","author":"Nikaido","year":"1999","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The importance of efflux pumps in bacterial antibiotic resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.micro.56.012302.161038","article-title":"Mechanisms of Solvent Tolerance in Gram-Negative Bacteria","volume":"56","author":"Ramos","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2958.2000.01926.x","article-title":"Multi-drug resistance mechanisms: Drug efflux across two membranes","volume":"37","author":"Zgurskaya","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-6445(03)00048-2","article-title":"Efflux-mediated heavy metal resistance in prokaryotes","volume":"27","author":"Nies","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molmed.2005.06.006","article-title":"Inhibitors of efflux pumps in Gram-negative bacteria","volume":"11","author":"Masi","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/scdb.2000.0246","article-title":"Phylogeny of multi-drug transporters","volume":"12","author":"Saier","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Morita, Y., Tomida, J., and Kawamura, Y. (2014). Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00422"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2004.08.003","article-title":"Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa","volume":"24","author":"Zhanel","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/138945008785747824","article-title":"Membrane permeability and regulation of drug \u201cinflux and efflux\u201d in enterobacterial pathogens","volume":"9","author":"Bolla","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/AAC.43.6.1340","article-title":"Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa","volume":"43","author":"Lomovskaya","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.77.7.3974","article-title":"Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli","volume":"77","author":"McMurry","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/204141","article-title":"Modulation of Bacterial Multi-drug Resistance Efflux Pumps of the Major Facilitator Superfamily","volume":"2013","author":"Kumar","year":"2013","journal-title":"Int. J. Bacteriol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.febslet.2011.04.054","article-title":"Strategies for bypassing the membrane barrier in multi-drug-resistant Gram-negative bacteria","volume":"585","author":"Bolla","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/jiu095","article-title":"Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs","volume":"210","author":"Adams","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-59745-246-5_15","article-title":"Bacterial Efflux Pump Inhibitors","volume":"Volume 142","author":"Champney","year":"2008","journal-title":"New Antibiotic Targets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157489109787236256","article-title":"Inhibitors of multi-drug-resistant efflux systems in bacteria","volume":"4","author":"Zechini","year":"2009","journal-title":"Recent Patents Anti-Infect. Drug Disc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.37.1.128","article-title":"Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multi-drug efflux transporter","volume":"37","author":"Neyfakh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2174\/138161211795703726","article-title":"Microbial Efflux Pump Inhibition: Tactics and Strategies","volume":"17","author":"Haynes","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.10.021","article-title":"Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view","volume":"71","author":"Lynch","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00284-009-9444-5","article-title":"Determination of the Efflux Pump-Mediated Resistance Prevalence in Pseudomonas aeruginosa, Using an Efflux Pump Inhibitor","volume":"59","author":"Tohidpour","year":"2009","journal-title":"Curr. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.phymed.2017.10.010","article-title":"An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG)","volume":"36","author":"Kanagaratnam","year":"2017","journal-title":"Phytomedicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.01033-06","article-title":"Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei","volume":"51","author":"Chan","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1128\/AAC.00661-08","article-title":"RamA Confers Multi-drug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine","volume":"52","author":"Bailey","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/138945006777709557","article-title":"Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multi-drug-resistant Enterobacter aerogenes isolates","volume":"7","author":"Mahamoud","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.46.8.2640-2643.2002","article-title":"The AcrAB-TolC Efflux Pump Contributes to Multi-drug Resistance in the Nosocomial Pathogen Enterobacter aerogenes","volume":"46","author":"Pradel","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.49.2.849-852.2005","article-title":"Selected Arylpiperazines Are Capable of Reversing Multi-drug Resistance in Escherichia coli Overexpressing RND Efflux Pumps","volume":"49","author":"Bohnert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jac\/dki446","article-title":"Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli","volume":"57","author":"Schumacher","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","first-page":"119","article-title":"New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors","volume":"5","author":"Chopra","year":"2002","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JCM.42.2.764-768.2004","article-title":"Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance","volume":"42","author":"Farrell","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ja.2015.101","article-title":"Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates","volume":"69","author":"Li","year":"2016","journal-title":"J. Antibiot."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1021\/acs.jmedchem.5b00428","article-title":"Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy","volume":"58","author":"Pieroni","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/CMR.1.1.109","article-title":"Beta-lactamase inhibitors from laboratory to clinic","volume":"1","author":"Bush","year":"1988","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: A guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-Spectrum -Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408410490266429","article-title":"Extended-Spectrum \u03b2-Lactamases (ESBLs): Characterization, Epidemiology and Detection","volume":"30","author":"Shah","year":"2004","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: The Versatile -Lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0190-9622(90)70121-W","article-title":"\u03b2-Lactamases, \u03b2-lactamase inhibitors, and skin and skin-structure infections","volume":"22","author":"Neu","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-198733060-00003","article-title":"Sulbactam\/Ampicillin: A Review of its Antibacterial Activity, Pharmacokinetic Properties, and Therapeutic Use","volume":"33","author":"Brogden","year":"1987","journal-title":"Drugs"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2165\/00003495-199447030-00008","article-title":"Piperacillin\/Tazobactam: A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Potential","volume":"47","author":"Bryson","year":"1994","journal-title":"Drugs"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/AAC.13.3.389","article-title":"In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin","volume":"13","author":"Wise","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/AAC.33.4.583","article-title":"Pseudomonas cepacia susceptibility to sulbactam","volume":"33","author":"Jacoby","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2014.01.003","article-title":"Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010\u20132012)","volume":"78","author":"Flamm","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/AAC.00206-15","article-title":"In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013","volume":"59","author":"Biedenbach","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.04191-14","article-title":"In Vitro Susceptibility of Characterized \u03b2-Lactamase-Producing Strains Tested with Avibactam Combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/jac\/dkv239","article-title":"Activity of OP0595\/\u03b2-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing \u03b2-lactamases","volume":"70","author":"Livermore","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a Cyclic Boronic Acid \u03b2-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/AAC.00843-15","article-title":"Activity of Meropenem Combined with RPX7009, a Novel \u03b2-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City","volume":"59","author":"Lapuebla","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mayocp.2014.12.002","article-title":"Emerging Issues in Gram-Negative Bacterial Resistance","volume":"90","author":"Vasoo","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"a025239","DOI":"10.1101\/cshperspect.a025239","article-title":"\u03b2-Lactamases: A Focus on Current Challenges","volume":"7","author":"Bonomo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","article-title":"Outer membrane permeability and antibiotic resistance","volume":"1794","author":"Delcour","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular Basis of Bacterial Outer Membrane Permeability Revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.str.2015.12.009","article-title":"Structural Insights into Outer Membrane Permeability of Acinetobacter baumannii","volume":"24","author":"Zahn","year":"2016","journal-title":"Structure"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/ja982938m","article-title":"Incremental Conversion of Outer-Membrane Permeabilizers into Potent Antibiotics for Gram-Negative Bacteria","volume":"121","author":"Li","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/AAC.50.5.1623-1627.2006","article-title":"Polyamines Increase Antibiotic Susceptibility in Pseudomonas aeruginosa","volume":"50","author":"Kwon","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","article-title":"Efflux-Mediated Drug Resistance in Bacteria: An Update","volume":"69","author":"Li","year":"2009","journal-title":"Drugs"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.2174\/092986710791331059","article-title":"Synthetic Membrane-Targeted Antibiotics","volume":"17","author":"Vooturi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","article-title":"Resistance to polymyxins: Mechanisms, frequency and treatment options","volume":"13","author":"Falagas","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.mib.2010.09.002","article-title":"Polymyxins and their novel derivatives","volume":"13","author":"Vaara","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ifset.2015.07.009","article-title":"Antibacterial activities and membrane permeability actions of glycinin basic peptide against Escherichia coli","volume":"31","author":"Li","year":"2015","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.sjbs.2015.09.004","article-title":"Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism","volume":"24","author":"Andrade","year":"2017","journal-title":"Saudi. J. Biol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.12.004","article-title":"Antimicrobial peptides: General overview and clinical implications in human health and disease","volume":"135","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1021\/ol048845t","article-title":"Synthesis and Characterization of Peptide\u2013Cationic Steroid Antibiotic Conjugates","volume":"6","author":"Ding","year":"2004","journal-title":"Org. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ar700270t","article-title":"Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides","volume":"41","author":"Lai","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide Antimicrobial Agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/ja973881r","article-title":"Design and Synthesis of Potent Sensitizers of Gram-Negative Bacteria Based on a Cholic Acid Scaffolding","volume":"120","author":"Li","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1358\/dnp.2008.21.6.1246829","article-title":"Ceragenins (Cationic Steroid Compounds), a novel class of antimicrobial agents","volume":"21","author":"Epand","year":"2008","journal-title":"Drug News Perspect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/ms.2014.45428","article-title":"Ceragenins\u2014A new weapon to fight multi-drug-resistant bacterial infections","volume":"3","author":"Surel","year":"2014","journal-title":"Med. Stud."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: Antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","article-title":"The biology and future prospects of antivirulence therapies","volume":"6","author":"Cegelski","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1080\/14756366.2018.1516652","article-title":"Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases","volume":"33","author":"Annunziato","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: Can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drup.2011.02.001","article-title":"Fighting bacterial infections\u2014Future treatment options","volume":"14","author":"Fernebro","year":"2011","journal-title":"Drug Resist. Updat."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrmicro1955","article-title":"Revisiting the host as a growth medium","volume":"6","author":"Brown","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00430-009-0123-8","article-title":"Survival of the fittest: How Brucella strains adapt to their intracellular niche in the host","volume":"198","author":"Roop","year":"2009","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152607781001772","article-title":"Drug targets in mycobacterial sulfur metabolism","volume":"7","author":"Bhave","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature04616","article-title":"Robust Salmonella metabolism limits possibilities for new antimicrobials","volume":"440","author":"Becker","year":"2006","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrd940","article-title":"The future challenges facing the development of new antimicrobial drugs","volume":"1","author":"Coates","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/sj.bjp.0707432","article-title":"Novel approaches to developing new antibiotics for bacterial infections","volume":"152","author":"Coates","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1099\/mic.0.2008\/020347-0","article-title":"L-Cysteine is required for induced antibiotic resistance in actively swarming Salmonella enterica serovar Typhimurium","volume":"154","author":"Turnbull","year":"2008","journal-title":"Microbiology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.resmic.2010.06.004","article-title":"Cysteine biosynthesis, oxidative stress and antibiotic resistance in Salmonella typhimurium","volume":"161","author":"Turnbull","year":"2010","journal-title":"Res. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics","volume":"130","author":"Kohanski","year":"2007","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/cbic.200600224","article-title":"Sulfate Metabolism in Mycobacteria","volume":"7","author":"Schelle","year":"2006","journal-title":"ChemBioChem"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bbapap.2011.04.011","article-title":"The multifaceted pyridoxal 5\u2032-phosphate-dependent O-acetylserine sulfhydrylase","volume":"1814","author":"Mozzarelli","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1016\/S0021-9258(18)62154-4","article-title":"Regulation of L-cysteine biosynthesis in Salmonella typhimurium. I. Effects of growth of varying sulfur sources and O-acetyl-L-serine on gene expression","volume":"246","author":"Kredich","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1021\/bi00076a017","article-title":"Kinetic mechanisms of the A and B isozymes of O-acetylserine sulfhydrylase from Salmonella typhimurium LT-2 using the natural and alternate reactants","volume":"32","author":"Tai","year":"1993","journal-title":"Biochemistry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/IAI.05152-11","article-title":"Transcriptome of Proteus mirabilis in the Murine Urinary Tract: Virulence and Nitrogen Assimilation Gene Expression","volume":"79","author":"Pearson","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"35551","DOI":"10.1074\/jbc.M805951200","article-title":"The CymR Regulator in Complex with the Enzyme CysK Controls Cysteine Metabolism in Bacillus subtilis","volume":"283","author":"Tanous","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.182345.111","article-title":"Identification of a target cell permissive factor required for contact-dependent growth inhibition (CDI)","volume":"26","author":"Diner","year":"2012","journal-title":"Genes Dev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/acs.jmedchem.5b01775","article-title":"Rational Design, Synthesis, and Preliminary Structure\u2013Activity Relationships of \u03b1-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella typhimurium O-Acetylserine Sulfhydrylase","volume":"59","author":"Pieroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/14756366.2016.1218486","article-title":"Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR","volume":"31","author":"Annunziato","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1039\/c2md20100c","article-title":"Design and synthesis of trans-2-substituted-cyclopropane-1-carboxylic acids as the first non-natural small molecule inhibitors of O-acetylserine sulfhydrylase","volume":"3","author":"Amori","year":"2012","journal-title":"MedChemComm"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/acs.jcim.7b00733","article-title":"Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets","volume":"58","author":"Annunziato","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/14756366.2018.1512596","article-title":"Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand\u2013based drug design","volume":"33","author":"Franko","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14756366.2018.1518959","article-title":"Refining the structure\u2013activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms","volume":"34","author":"Franko","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1021\/acs.jmedchem.6b00674","article-title":"Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis","volume":"59","author":"Brunner","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/14756366.2018.1504040","article-title":"Inhibition of O-acetylserine sulfhydrylase by fluoroalanine derivatives","volume":"33","author":"Franko","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1021\/bi00666a028","article-title":"Inactivation of pyridoxal phosphate dependent enzymes by mono- and polyhaloalanines","volume":"15","author":"Silverman","year":"1976","journal-title":"Biochemistry"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-5793(81)80102-0","article-title":"Inactivation of \u03bb-cystathionase by \u03bb-fluorinated amino acids","volume":"128","author":"Alston","year":"1981","journal-title":"FEBS Lett."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/14756366.2015.1050010","article-title":"Inhibitors of alanine racemase enzyme: A review","volume":"31","author":"Azam","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0003-9861(92)90602-S","article-title":"Indole protects tryptophan indole-lyase, but not tryptophan synthase, from inactivation by trifluoroalanine","volume":"296","author":"Phillips","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1039\/b517922j","article-title":"Suicide inhibition of \u03b1-oxamine synthases: Structures of the covalent adducts of 8-amino-7-oxononanoate synthase with trifluoroalanine","volume":"4","author":"Alexeev","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/1568026614666140202204602","article-title":"Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments","volume":"14","author":"Tysoe","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1432-1033.1972.tb02510.x","article-title":"Evidence for Induced Fit of a Pseudo-Substrate of Aspartate Aminotransferase","volume":"31","author":"John","year":"1972","journal-title":"Eur. J. Biochem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1742-4658.2011.08106.x","article-title":"Human kynurenine aminotransferase II\u2014Reactivity with substrates and inhibitors: Reactivity of kynurenine aminotransferase","volume":"278","author":"Passera","year":"2011","journal-title":"FEBS J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"a012427","DOI":"10.1101\/cshperspect.a012427","article-title":"Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control","volume":"2","author":"Rutherford","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cell.2006.04.001","article-title":"Bacterially Speaking","volume":"125","author":"Bassler","year":"2006","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/mic.0.038794-0","article-title":"Quorum sensing in bacterial virulence","volume":"156","author":"Antunes","year":"2010","journal-title":"Microbiology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/acs.jmedchem.5b01698","article-title":"Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections","volume":"59","author":"Wagner","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/cr100109t","article-title":"Quorum Sensing in Gram-Negative Bacteria: Small-Molecule Modulation of AHL and AI-2 Quorum Sensing Pathways","volume":"111","author":"Galloway","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/b703021p","article-title":"Expanding dialogues: From natural autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria","volume":"37","author":"Geske","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"K\u00f6hler, T., Perron, G.G., Buckling, A., and van Delden, C. (2010). Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000883"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., and Tzika, A. (2014). Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004321"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ilangovan, A., Fletcher, M., Rampioni, G., Pustelny, C., Rumbaugh, K., Heeb, S., C\u00e1mara, M., Truman, A., Chhabra, S.R., and Emsley, J. (2013). Structural Basis for Native Agonist and Synthetic Inhibitor Recognition by the Pseudomonas aeruginosa Quorum Sensing Regulator PqsR (MvfR). PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003508"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2016.08.014","article-title":"A novel, multi-barrier, drug eluting calcium sulfate\/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model","volume":"239","author":"Mistry","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"De la Fuente-N\u00fa\u00f1ez, C., Reffuveille, F., Haney, E.F., Straus, S.K., and Hancock, R.E.W. (2014). Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004152"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms","volume":"58","author":"Reffuveille","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting microbial biofilms: Current and prospective therapeutic strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.mib.2013.06.013","article-title":"Bacterial biofilm development as a multicellular adaptation: Antibiotic resistance and new therapeutic strategies","volume":"16","author":"Reffuveille","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: An emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tim.2014.02.001","article-title":"Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms","volume":"22","author":"Coenye","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/5844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:23Z","timestamp":1760189783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/5844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":147,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["ijms20235844"],"URL":"https:\/\/doi.org\/10.3390\/ijms20235844","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}